Click/Tap me for context
Note: Evidence is robust for thyroid/developmental roles via decades of public health data; non-thyroid benefits require more high-quality trials. Urinary iodine concentration is the main status biomarker (adequate: 100–199 μg/L general; 150–249 μg/L pregnant). Each individual is unique and requires a doctor to assess the dosage they need, if a deficiency/excess is established.
1. Essential for Thyroid Hormone Production and Metabolic Regulation
Evidence Strength: Strong
Iodine is a structural component of T3 and T4. These hormones control protein synthesis, enzymatic activity, metabolic rate, and functions in the liver, kidneys, muscles, brain, and central nervous system. Deficiency impairs hormone production, leading to hypothyroidism. Adequate iodine maintains normal thyroid function and metabolism across all life stages.
Evidence: Universally supported by NIH ODS, LPI reviews, and multiple systematic reviews. Thyroid hormones are the primary mechanism; supplementation or iodized salt normalizes function in deficient populations.
2. Prevention of Iodine Deficiency Disorders (IDDs) and Goiter
Evidence Strength: Strong
Iodine deficiency causes a spectrum of disorders, including goiter (thyroid enlargement), hypothyroidism, hyperthyroidism, and growth impairments. Severe deficiency leads to endemic goiter and cretinism. Public health interventions like salt iodization have dramatically reduced prevalence worldwide (89% of households now have access).
Note: For mild-to-moderate iodine deficiency, the thyroid can often compensate enough to keep most people euthyroid (normal hormone levels) by working harder and growing. However, this chronic stimulation promotes nodular changes in the thyroid over time. Some nodules become autonomous (they produce hormones independently of TSH regulation). These can lead to toxic nodular goiter and hyperthyroidism (excess hormone production).
Evidence: WHO states IDDs jeopardize mental health and survival, causing stillbirth, spontaneous abortion, congenital abnormalities, and pervasive mental impairment. Salt iodization and supplementation programs are highly effective public health measures. Historical trials (e.g., Marine’s 1917 study) and long-term data confirm goiter reduction.
3. Support for Fetal, Infant, and Pregnancy Outcomes
Evidence Strength: Strong (for severe deficiency and status improvement); Moderate for routine supplementation in mild deficiency.
Iodine is critical during pregnancy and lactation because the fetus relies on maternal T4 (especially early in gestation) for brain and skeletal development. Deficiency increases risks of preeclampsia, miscarriage, preterm birth, low birth weight, stillbirth, congenital hypothyroidism, and neurocognitive deficits. Adequate intake supports proper fetal neurological growth and maturation.
Evidence: NIH ODS and LPI emphasize this as a key role; severe deficiency causes cretinism (irreversible intellectual disability, growth issues, deafness). WHO and guidelines (American Thyroid Association, American Academy of Pediatrics) recommend supplementation (150–250 mcg/day) for women of reproductive age, pregnant, or lactating in deficient areas to meet increased needs (RDA: 220 mcg pregnant, 290 mcg lactating). RCTs and reviews show improved maternal iodine status, reduced thyroglobulin, and stabilized thyroid volume.
4. Cognitive and Neurodevelopmental Benefits in Children
Evidence Strength: Strong (moderate-severe deficiency and population programs); Moderate (mild deficiency and supplementation).
Chronic deficiency (even mild-moderate) impairs brain development, reducing IQ and school performance. In children, it links to learning disabilities and poorer cognitive function. Supplementation in deficient children improves outcomes.
Evidence: Meta-analyses of observational studies show 7–13.5 IQ point reductions in deficient children. A 2009 RCT (New Zealand children, mildly deficient) found 150 mcg/day iodine for 28 weeks improved perceptual reasoning, matrix reasoning, and overall cognitive scores (0.19 SD higher). Cochrane review: Supplementation positively affects physical/mental development and reduces mortality in deficient areas. Benefits are clearest in moderate-severe deficiency; mild cases show subtler gains.
5. Thyroid Protection Against Radioactive Iodine (Radiation Emergencies)
Evidence Strength: Strong
Potassium iodide (KI) saturates the thyroid with stable iodine, blocking uptake of radioactive iodine (I-131) and reducing thyroid cancer risk.
Evidence: Established by FDA, CDC, WHO, American Thyroid Association, and NRC guidelines. Effective if taken before/during exposure (optimal within hours; protection lasts ~24 hours). Post-Chernobyl data and modeling confirm reduced cancer risk, especially in children/pregnant women. Not a general radiation antidote—only for radioiodine. Dosing is age-specific and short-term.
Additional Notes
*Generally* recommended dosage:
Adults: 150 mcg/day
Pregnant: 220 mcg/day
Lactating: 290 mcg/day
Children: 90–150 mcg/day (varies by age)
Infants: 110–130 mcg/day (Adequate Intake)
Bioavailability: Iodine (as iodide) is already highly absorbed (>90% in stomach/small intestine). No major practical ways to significantly increase it for most people.
Selenium helps thyroid use of iodine (e.g., 1–2 Brazil nuts/day).
Prefer iodized salt, seafood, or dairy over supplements unless deficient (test via urinary iodine or consult doctor).
Limitations: Benefits are primarily from preventing/correcting deficiency. In iodine-sufficient populations, extra supplementation offers little added value and risks excess (e.g., hyperthyroidism, thyroid dysfunction). Pregnant/lactating women and young children are most vulnerable to deficiency. Stick to food sources; supplement only if needed under medical advice. Excess can harm the thyroid.
Sources
- Assessment of the Impact of Salt Iodisation Programmes on Urinary Iodine Concentrations and Goitre Rates: A Systematic Review
- Use of potassium iodide for thyroid protection during nuclear or radiological emergencies
- Iodine supplementation improves cognition in mildly iodine-deficient children1-3
- Raising IQ among school-aged children: Five meta-analyses and a review of randomized controlled trials
- The effects of iodine on intelligence in children: a meta- analysis of studies conducted in China
- Iodine and Mental Development of Children 5 Years Old and Under: A Systematic Review and Meta-Analysis
- Maternal Iodine Status During Pregnancy and Child Neurodevelopment: A Systematic Review and Dose–Response Meta-Analysis of Prospective Cohort Studies
- Effects of iodine supplementation during pregnancy on pregnant women and their offspring: a systematic review and meta-analysis of trials over the past 3 decades Get access Arrow
- Systematic review and meta-analysis of the effects of iodine supplementation on thyroid function and child neurodevelopment in mildly-to-moderately iodine-deficient pregnant women
- Effect of inadequate iodine status in UK pregnant women on cognitive outcomes in their children: results from the Avon Longitudinal Study of Parents and Children (ALSPAC)
- Effect and safety of salt iodization to prevent iodine deficiency disorders: a systematic review with meta-analyses
- Iodine
- Iodine: Fact Sheet for Health Professionals
- Iodization of salt for the prevention and control of iodine deficiency disorders
- Iodine Deficiency and Iodine Prophylaxis: An Overview and Update
- Iodine Deficiency Guidelines
- Potassium Iodide (KI)

